Pasquale Esposito*, Lorenzo Nescis and Francesca Viazzi Pages 3052 - 3059 ( 8 )
ANCA-vasculitis, rituximab, maintenance treatment, avacopan, B-cells, complement, recurrence, CAR T-cells.